$15.6 Million Investment In Parion’s Pulmonary Research Program Might Have Huge Impact In Pulmonary Diseases
COPD, News
A five-year, $15.6 million award was recently announced for supporting continued research into mucolytic agents developed by Parion Sciences and to enable Investigational New Drug (IND) applications for these molecules. The funding ... Read more